Ginsenoside Rb3 inhibits angiotensin ii-induced vascular smooth muscle cells proliferation

Basic and Clinical Pharmacology and Toxicology

Volumn 107, Issue 2, 2010, Pages 685-689

  Wang, Tian ^a,b   Yu, Xiao Feng ^a   Qu, Shao Chun ^a   Xu, Hua Li ^a   Sui, Da Yuan ^a  

^a JILIN UNIVERSITY   (China)

^b YANTAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; GINSENOSIDE; GINSENOSIDE RB 3; MESSENGER RNA; UNCLASSIFIED DRUG; DNA; GINSENOSIDE RB3; PLANT EXTRACT;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; MALE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; ONCOGENE C MYC; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CELL CYCLE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; GINSENG; SPRAGUE DAWLEY RAT; THORACIC AORTA;

RATTUS;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; DNA; DRUG ANTAGONISM; GINSENOSIDES; MALE; MUSCLE, SMOOTH, VASCULAR; PANAX; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77954695980     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00560.x     Document Type: Article

References (16)

1. Dubey RK, Jackson EK, Luscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. J Clin Invest 1995 96 : 141 149.
2. Inagami T, Iwai N, Sasaki K, Yamamo Y, Bardhan S, Chaki S et al. Cloning, expression and regulation of angiotensin II receptors. J Hypertens 1992 10 : 713 716.
3. Aplin M, Bonde MM, Hansen JL. Molecular determinants of angiotensin II type 1 receptor functional selectivity. J Mol Cell Cardiol 2009 46 : 15 24.
4. Marrero MB, Schieffer B, Paxton WG, Duff JL, Berk BC, Bernstein KE. The role of tyrosine phosphorylation in angiotensin II-mediated intracellular signalling. Cardiovasc Res 1995 30 : 530 536.
5. Xi XP, Graf K, Goetze S, Hsueh WA, Law RE. Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells. FEBS Lett 1997 417 : 283 286.
6. Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen CJ. Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. Med Sci Monit 2004 10 : RA187 92.
7. Wang Z, Li M, Wu WK, Tan HM, Geng DF. Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction. Cardiovasc Drugs Ther 2008 22 : 443 452.
8. Xie JT, Shao ZH, Vanden Hoek TL, Chang WT, Li J, Mehendale S et al. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 2006 532 : 201 207.
9. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999 58 : 1685 1693.
10. Wang Y, Yan T, Wang Q, Wang W, Xu J, Wu X et al. PKC-dependent extracellular signal-regulated kinase 1/2 pathway is involved in the inhibition of Ib on AngiotensinII-induced proliferation of vascular smooth muscle cells. Biochem Biophys Res Commun 2008 375 : 151 155.
11. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 362 : 801 809.
12. Zhou CH, Wu XH, Wu YQ. Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway. Eur J Pharmacol 2009 615 : 55 60.
13. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation 1998 98 : 82 9.
14. Luttrell LM, Daaka Y, Lefkowitz RJ. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 1999 11 : 177 183.
15. Touyz RM, El Mabrouk M, He G, Wu XH, Schiffrin EL. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res 1999 84 : 505 515.
16. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension 1998 31 : 152 161.